CD8A and neoplasm: AGK (Acylglycerol kinase) is a positive regulator of CD8+ T cells glycolysis (glucose metabolism) which is a prerequisite for effector CD8+ T cells proliferation and activity, while CD8+ T cells play a pivotal role in adaptive anti-tumor immunity to eliminate cancer cells [107].